• Identification of advanced form of idronoxil
• Study in support of marketing application for NOX66
• Dosage form specific for urogenital cancers in women
Sydney, 27 March 2017: A contract research project being conducted by Monash University for Noxopharm has been awarded $50,000 by the Australian Government Entrepreneurs’ Programme under its Innovation Connections Grant Funding scheme.
The collaboration with Monash University’s Institute of Pharmaceutical Science involves separate programs with two main objectives.
For further information please download PDF attached:
Download this document
